Avon Lifesciences informs about conversion of warrants into equity

28 Nov 2015

Avon Lifesciences has informed that as per the terms of 10,500,000 Warrants issued by the Company on August 12, 2015 on preferential basis, the Allotment Committee of the Board of Directors of the Company at the meeting held on November 27, 2015, has upon receipt of balance of 75% consideration aggregating to Rs.1,950,000 has approved allotment of 100,000 Equity Shares upon conversion of equivalent number of warrants at an issue price of Rs. 26 per share.

The above information is a part of company’s filings submitted to BSE.

Related Avon Lifesciences Ltd. Links:

Avon Lifescien Share Price

7.83 -0.15 (-1.88%) Sep 28, 18:02
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 510.20
Dr. Reddys Lab 5127.15
Lupin 1007.85
Piramal Enterprises 1283.90
Cadila Healthcare 390.50
View more..
Sensex vs Avon Lifescien
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback